行情

ACHV

ACHV

Achieve
NASDAQ

实时行情|Nasdaq Last Sale

8.28
+0.31
+3.89%
盘后: 8.70 +0.42 +5.07% 19:52 09/17 EDT
开盘
8.50
昨收
7.97
最高
8.50
最低
8.07
成交量
17.77万
成交额
--
52周最高
16.10
52周最低
6.63
市值
7,826.44万
市盈率(TTM)
-1.6292
分时
5日
1月
3月
1年
5年
LCID、SDC 和 ABCL 是上市前的赢家
Corvus Pharmaceuticals (NASDAQ:CRVS) +56%. Innate Pharma (NASDAQ:IPHA) +32% Monalizumab data from COAST trial presented at ESMO Congress 2021 Surface Oncology (NASDAQ:SURF) +14%. BeiGene (NASDAQ:BGNE) +13% on positive DKN-01 + tislelizumab data in gastroes...
Seekingalpha · 17小时前
Achieve Life Sciences 参加即将举行的投资者会议
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 15, 2021/ Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotin...
ACCESSWIRE · 2天前
Achieve Life Sciences 宣布在第 21 届尼古丁和烟草研究学会 (SRNT-E) 虚拟会议上展示胞嘧啶数据
SEATTLE, WA & VANCOUVER, BC / ACCESSWIRE / September 14, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
ACCESSWIRE · 3天前
Achieve Life Sciences 参加即将举行的两场投资者会议
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 9, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotin...
ACCESSWIRE · 09/09 09:30
The Daily Biotech Pulse:AzurRx 关注数据,Agios 的 Mitapivat 监管申请获得优先审查接受,FDA 批准葛兰素史克
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)
Benzinga · 08/18 11:37
The Daily Biotech Pulse:礼来重组神经科学业务部门,Helius Medical 获得突破性指定,Ra Medical 出售皮肤科业务
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)
Benzinga · 08/17 12:28
ACHV:ORCA-2 完全注册
By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT Second Quarter 2021 Results Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported second quarter results in a press release and held a conference call after market close on August 12, 20...
Zacks Small Cap Research · 08/16 09:10
Achieve Life Sciences 宣布扩大胞嘧啶临床运营团队
Achieve Life Sciences, Inc. (NASDAQ: ACHV) today announced that the Company has expanded its Clinical Operations Team with the hiring of a Director of Clinical Operations, a Senior Manager of Clinical Trials, and a Senior Director of Biometrics.
Benzinga · 08/13 09:33
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解ACHV最新的财务预测,通过ACHV每股收益,每股净资产,每股现金流等数据分析Achieve近期的经营情况,然后做出明智的投资选择。
分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测ACHV价格均价为36.71,最高价位80.00,最低价为20.00。
EPS
机构持股
总机构数: 46
机构持股: 257.34万
持股比例: 27.22%
总股本: 945.22万
类型机构数股数
增持
8
55.02万
建仓
17
76.96万
减持
3
4.82万
平仓
4
33.03万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.49%
制药与医学研究
-0.10%
高管信息
Chairman/Executive Director
Richard Stewart
President/Director
Cindy Jacobs
Chief Executive Officer/Director
John Bencich
Chief Accounting Officer
Jerry Wan
Chief Scientific Officer
Anthony Clarke
Lead Director/Independent Director
Donald Joseph
Independent Director
Bridget Martell
Independent Director
Martin Mattingly
Independent Director
Jay Moyes
暂无数据
ACHV 简况
Achieve Life Sciences Inc是一家处于临床阶段的制药公司。该公司从事用于戒烟和尼古丁成瘾的胞嘧啶碱的开发和商业化。该公司的候选产品cytisinicline是一种天然存在的植物性生物碱,来自Laburnum anagyroides植物的种子。Cytisinicline在结构上与尼古丁相似,具有激动和拮抗的作用机制。该产品有助于戒烟,或尼古丁成瘾,通过与大脑中的尼古丁受体相互作用,通过对尼古丁受体的激动作用降低尼古丁戒断症状的严重程度,并通过拮抗特性降低与尼古丁相关的奖赏和满足感。

微牛提供Achieve Life Sciences Inc(NASDAQ-ACHV)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ACHV股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ACHV股票基本功能。